Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cell Impact's rights issue is oversubscribed

Cell Impact AB (publ) (Nasdaq First North Growth Market: CI B) ("Cell Impact" or the "Company") announces that the preliminary outcome for the rights issue (the "Rights Issue"), for which the subscription period ended on December 23, 2021, indicates that the Rights Issue is oversubscribed and that no guarantee commitments will need to be utilized. The Rights Issue will provide the Company with approximately SEK 349 million before deduction of transaction costs related to the Rights Issue.THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO

Nordea Bank Abp: Repurchase of own shares on 23.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares23.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 23.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 366,005 10.43 3,816,677.90XHEL 270,738 10.42 2,822,389.50CEUX 292,883 10.43 3,054,057.57AQEU 44,441 10.43

Vestas secures 301 MW order of EnVentus turbines from TransAlta in the USA

News release from Vestas-American Wind TechnologyPortland, 23 December 2021 Vestas has received a 301 MW order from TransAlta Corporation (“TransAlta”) to power two wind projects, White Rock East and White Rock West, in Oklahoma, USA. The order consists of 33 V162-6.0 MW turbines and one V136-3.45 MW turbine at White Rock East and 16 V162-6.0 MW turbines and one V136-3.45 MW turbines at White Rock West, respectively. “In our pursuit to quickly and effectively scale the wind industry in the US, Vestas is thrilled to partner with TransAlta to deliver clean energy to Oklahoma”, said

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 20 December 2021 – 23 December 2021, acquired a total of 63,500 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 3 December 2021, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period

Integrum to support the US Department of Veterans Affairs program to expand care for Veterans who have experienced limb loss

Mölndal, Sweden, December 23, 2021 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announced today its plans to support the US Department of Veterans Affairs program to offer the OPRA™ Implant System to select Veterans who meet criteria for the implant system.The Department of Veterans Affairs (VA) administers the largest integrated health care system in the United States, providing care at nearly 1,300 health care facilities to over 9 million military Veterans enrolled in the VA health care program. The VA has developed a process by which Veterans can be evaluated to

Sandvik completes the acquisition of software provider ICAM

Sandvik has completed the previously announced acquisition of the Canada-based ICAM Technologies Corporation, a provider of innovative solutions that translate CAM data into optimized coding for guiding CNC machining operations. In 2020, the company had revenues of approximately SEK 30 million and an EBITA margin of approximately 25%. The company will be reported in Coromant, a division within the business area Sandvik Manufacturing and Machining Solutions. Stockholm, December 23, 2021 Sandvik AB For further information, contact Louise Tjeder, VP Investor relations, phone:

ASSA ABLOY acquires Małkowski-Martech in Poland

ASSA ABLOY has acquired approximately 85.7% of the shares in Małkowski-Martech S.A. (“the Company”), from the Małkowski family, through an off-market transaction. The purchase price for the 85.7% of the shares in the Company amounts to approximately MPLN 33.Małkowski-Martech is a Polish producer of fire rated curtains and gates, listed on the Warsaw Stock Exchange, NewConnect market. "I am very pleased to welcome Małkowski-Martech into the ASSA ABLOY Group. I welcome this complementary business, specializing in fire rated curtains and gates,” says Nico Delvaux, President and CEO of ASSA

Sedana Medical receives IND approval for US trials

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to initiate phase III pivotal clinical trials with its Sedaconda products in the United States.Sedana Medical is aiming for a combination registration of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane) for sedation of mechanically ventilated intensive care patients. As previously announced, the company is planning to commence patient recruitment at the turn of Q1/Q2 2022, with the

Cary Group strengthens its position in Norway and continues to expand its operations

Cary Group has signed an agreement to acquire 100% of Norwegian company MPS Bilskade AS, “MPS Bilskade”, which operates within both minor and major vehicle damage repair. The acquisition represents an expansion on the Norwegian market for existing customers and strengthens Cary Group’s market position in Norway.“We are pleased to welcome MPS Bilskade to the Cary Group family. This acquisition will enable us to offer additional services, with more workshops for carrying out both minor and major auto body repair. With its large network of workshops across the whole of Norway, the

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.12.2021

United Bankers Plc NOTIFICATION 23.12.2021 at 18:30 UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.12.2021 Date 23.12.2021Exchange transaction BuyShare class UNITEDAmount 322Average price/share 13.7000 EURHighest price/share 13.7000 EURLowest price/share 13.7000 EURTotal price 4,411.40 EUR The shares held by United Bankers Plc on 23.12.2021: UNITED 55,805 On behalf of United Bankers Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 23.12.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 23.12.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 23.12.2021 Date 23.12.2021Exchange transaction BuyShare class ALEXAmount 210Average price/share 8.1000 EURHighest price/share 8.1000 EURLowest price/share 8.1000 EURTotal price 1,701.00 EUR The shares held by Alexandria Pankkiiriliike Oyj on 23.12.2021: ALEX 43,853 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Terveystalo Plc: SHARE REPURCHASE 23.12.2021

Terveystalo Plc ANNOUNCEMENT  23.12.2021 Terveystalo Plc: SHARE REPURCHASE 23.12.2021 In the Helsinki Stock Exchange Trade date           23.12.2021Bourse trade         BuyShare                  TTALOAmount             24 000 SharesAverage price/ share    11,5591 EURTotal cost            277 418,40 EUR Terveystalo Plc now holds a total of 1 676 382 sharesincluding the shares repurchased on 23.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Getinge acquires Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions

Getinge announces the acquisition of 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical’s offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor and delivery episodes and critical care support including ECMO Therapy.“Connecting life-saving medical devices with other data sources and presenting the right data to the right clinician is instrumental in supporting better patient outcomes and lower treatment costs”, says Jens

#21-425 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-424  Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Traveling to Thailand from 24 December 2021

Information updated 23 December 2021 Thailand Pass is temporarily closed for all new Test & Go and Sandbox applications (except Phuket Sandbox), effective from 22 December 2021 until further notice. To visit Thailand, all travellers are required to register and present documents through Thailand Pass . Register online no later than 7 days before departure. All travellers must download and install the MorChana application. Travellers who already applied for Thailand Pass · Travellers who already received their

Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice

Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena Edlund of a new study demonstrating the prevention and reversal of gene expression and epigenetic changes to beta cells in diet-induced obese mice. Treatment with O304 prevented genome-wide gene expression changes associated with high fat diet and remodelled active and repressive chromatin markers in beta cells, the cells responsible for producing the body’s insulin.  Glucose control was restored in the animals and markers of stress were reduced and

CS MEDICA A/S: Update on IPR rights

CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces that an additional five Intellectual Property Rights (IPR) registrations have been made for CANNASEN, and the Company hereby provides an update on the Company’s IPR and trademark.CS MEDICA’s product line, CANNASEN® CBD is the world’s first over-the-counter medical technical treatment products with cannabinoids. Intellectual Property Rights (IPR) is a key element for CS MEDICA to ensure economic growth and is continually extended when entering new markets. CS MEDICA can now confirm that the Company has officially completed an

Provident CRM achieves record revenue and most profitable year in the company’s history in 2021

2021 company & financial highlights: · Record monthly billing in excess of €1M for the first time in September 2021 · 67% increase in YoY Operating Profits to end November 2021 · Recruitment expansion in 2021, helping employee count to surpass 50 for 1st time · Positive trends in the industry and partner’s products“Provident CRM had another outstanding year as our partners’ solutions continue to transform customer relationships, improve processes, and drive business success in a digital-first world”, said John Malone, CEO & Founder, Provident CRM. “Our talented employees,

Company Announcement No. 126, 2021 – EURIBOR3, Fixing of coupons with effect as from 1 January 2022

The coupons for the FRNs listed below will change taking effect 1 January 2022. The new coupons will be in force from 1 January 2022 – 31 March 2022.   FRNs without interest rate cap, EURIBOR3:    ISIN-code DK0002048974, maturity 2024, new coupon as per 1 January 2022: -0.36% p.a.   ISIN-code DK0002052497, maturity 2025, new coupon as per 1 January 2022: -0.45% p.a.   Questions can be directed to Torben Jurlander phone no. +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

Navamedic ASA: Trading Update

Oslo, 23 December 2021 – Navamedic ASA (OSE: NAVA) today announces a trading update based on updated revenue growth expectation for the full-year 2021 of around 30%, compared to the previously communicated annual growth target of 20%. The revenue growth is driven by strong performance in Q4 with a particularly strong December month.Reference is made to Navamedic’s communicated target of 20% annual growth for 2021. As the company’s preliminary financial results for Q4, and hence the full year 2021, represent a noticeable improvement compared to the communicated target for 2021, the company

Oda places order worth approximately 750 000 EUR

Norwegian based company Oda, a leading company for online sales of groceries, has placed another order with FlexQube worth approximately 750 000 EUR. The delivery will take place during the first half of 2022 to a new site in Norway.  CEO Anders Fogelberg comments: ”The large order, worth approximately 1.2 MEUR, that was accounced on December 22nd is now followed by another large order from Oda. These two orders combined means that the order intake in the fourth quarter just from Oda will reach almost 20 MSEK, which is fantastic. The previously communicated framework agreement with

Towards 2022 – A message from Brighter’s CEO

As we reach the end of the year and take a break to spend time with our loved ones, I wanted to send a message reminding you of Brighter’s reason for being. Today, more than 537 million people around the world are living with diabetes. That number is forecast to grow to 784 million by 2045 – an increase equivalent to three times the population of Germany. Living with diabetes can be extremely challenging, requiring special attention to diet, exercise and often medication. Besides these personal challenges, diabetes also represents a massive cost to healthcare systems around the world.

There are no items matching the current filter
There are no more items matching the current filter
Back to top